Standard Glass Lining Technology Limited has informed the Exchange about Investor Presentation
Date: August 04, 2025
To, Listing Compliance Department BSE Limited Phiroze Jeejeebhoy Towers Dalal Street, Mumbai - 400 001
Listing Compliance Department National Stock Exchange of India Limited Exchange Plaza, C-1 Block G, Bandra - Kurla Complex, Bandra (East) Mumbai - 400 051
SCRIP CODE: 544333
SYMBOL: SGLTL
Dear Sir/Madam,
Sub: Investor Presentation on the Financial Results for the quarter ended June 30 2025
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. please find enclosed the Investor Presentation on the Financial Results for the quarter ended June 30 2025.
You are requested to kindly take the above information on record.
Thanking you,
Yours faithfully,
For STANDARD GLASS LINING TECHONOLOGY LIMITED
Kallam Hima Priya Company Secretary & Compliance Officer
Standard Glass Lining Technology Limited
Registered office: D-12, Phase-I, IDA Jeedimetla, Hyderabad -500055 Corporate Office: 10th Floor, PNR High Nest, Hydernagar, KPHB Colony, Hyderabad- 500085 Manufacturing Unit: Survey No. 42/A, Alinagar, Chetlapotharam Village, Gaddapotharam, SangaReddy- 501319
CIN: L29220TG2012PLC082904 Email: corporate@standardglr.com Website: www.standardglr.com Tel: + 040 3518 2204
Standard Glass Lining Technology Limited
Investor Presentation
Aug 2025
1
Disclaimer
This presentation and the accompanying slides (the “Presentation”), have been prepared by Standard Glass Lining Technology Limited (the “Company”) solely for information purposes and do not constitute any offer, recommendation, or invitation to purchase or subscribe for any securities and shall not form the basis or be relied on in connection with any contract or binding commitment whatsoever. No offering of securities of the Company will be made except by means of a statutory offering document containing detailed information about the Company.
Certain statements in this presentation concerning our future growth prospects are forward-looking statements that involve a number of risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. The Risk and uncertainties relating to the statements include but are not limited to, risks and uncertainties regarding fiscal policy, competition, inflationary pressures, climate and general economic conditions affecting demand/supply and price conditions in domestic and international markets. The Company does not undertake to update any forward-looking statement that may be made from time to time by or on behalf of the Company.
This Presentation has been prepared by the Company based on information and data which the Company considers reliable. This Presentation may not be all-inclusive and may not contain all of the information that you may consider material. Any liability in respect of the contents of, or any omission from, this Presentation is expressly excluded. The Company does not make any promise to update/provide such a presentation along with results to be declared in the coming quarters and years.
‹#›2
Table of Content
Quarter Performance Q1FY26
Business Overview
Annexure
3 ‹#›
QUARTER PERFORMANCE- Q1FY26
BUSINESS OVERVIEW
ANNEXURE
44
A Message from the MD
Nageswara Rao Kandula
Promoter and Managing Director - Standard Glass Lining Technology Limited
We are pleased with our continue healthy performance this quarter, which reflects our unwavering commitment to our customers, investors and all stakeholders. Through improved execution, we have delivered good margins while also expanding our exports and establishing our global footprint. Our focus on innovation has enhanced our reputation with customers, and our new offerings are gaining acceptance and appreciation. We remain confident that our efforts in technology development, product diversification, and international market expansion will open new avenues for sustainable, long-term growth. We also believe that the rapid growth of the CDMO business in India presents a significant opportunity for the Indian engineering industry. As global pharma and chemical companies increasingly turn to India for high-quality, cost-effective manufacturing solutions, we are well- positioned to benefit from this trend—thanks to our strong customer relationships, proven execution capabilities, and engineering excellence
5 ‹#›
COO’ Comment
Venkata Mohana Rao Katragadda
Promoter and Executive Director - Standard Glass Lining Technology Limited
This quarter’s performance is a testament to the operational discipline and collaborative effort across our teams. We have made meaningful progress in streamlining production processes, improving delivery timelines, and ensuring cost-effective execution without compromising on quality. Our initiatives on automation, lean manufacturing, and capacity optimization are showing encouraging results. Additionally, the R&D and engineering teams are making steady headway in developing next-generation products, which will further strengthen our market position in the coming periods.
6 ‹#›
Latest Strategic Updates
Incorporated Standard Engineering Inc. as a wholly owned subsidiary of the Company
•
Based in the State of South Carolina, USA - a growing hub for industrial manufacturing
• Will cater to Industrial Products and Process Equipment segment
• Marks a significant step in the Company’s international growth strategy and
customer proximity
•
•
•
•
•
Expected to enhance supply chain responsiveness and unlock new customer opportunities in the North American market
Entered into a long-term agency agreement with M/s. Biocon Solutions Pte Ltd, Singapore
Covers key Southeast Asian territories- Singapore, Indonesia, Malaysia, and Thailand
Enables export of Standard’s manufactured products to BioCon’s customers
Strengthens our international footprint and opens access to new industrial customers in high-growth markets
Combines Standard's manufacturing excellence with BioCon’s market reach and distribution network
7 ‹#›
Earnings at Glance: Q1FY26
Total Income ₹ 178 Cr 23.6 % YoY
EBITDA ₹ 35 Cr 31.9 % YoY
PBT ₹ 28 Cr 39.6 % YoY
PAT ₹ 21 Cr 37.6 % YoY
01
02
Sales growth during the quarter was driven by timely execution and delivery of key projects and exports
EBITDA Margins at 19.5%; improvement led by Favorable product mix and export contribution with better pricing
03 Robust PAT Growth: Driven by strong revenue expansion and healthy EBITDA performance, reflecting improved
operating leverage and cost efficiency
8 ‹#›
Quarter Financial Highlights
Total Income (In Cr.)
EBITDA & Margins (%)
PAT & Margins (%)
18.2%
19.5%
10.7%
11.9%
23.6 %
31.9%
37.6%
144
178
35
26
21
15
Q1FY25
Q1FY26
Q1FY25
Q1FY26
Q1FY25
Q1FY26
9 ‹#›
Q1FY26 Financial Performance
Particulars (Rs Cr)
Revenue from Operations
Other Income
Total Income
Total Expenditure
EBITDA
EBITDA Margin %
Depreciation
Profit Before Interest & Tax
Interest
Profit Before Tax
Tax
Net Profit
PAT Margin (%)
Diluted Earnings Per Share (Rs)
Q1FY26
Q1FY25
173.1
5.1
178.2
143.5
34.7
19.5%
3.6
31.0
2.6
28.5
7.3
21.1
11.9%
1.1
141.8
2.3
144.1
117.9
26.3
18.2%
2.3
23.9
3.5
20.4
5.0
15.4
10.7%
0.8
YoY
22.0%
121.1%
23.6%
21.8%
31.9%
123 bps
54.9%
29.7%
-27.6%
39.6%
45.8%
37.6%
120 bps
-
10 ‹#›
Revenue By Segment
By Line of Business
By End Users Industries
By Geography
Q1FY26
24.9%
31.2%
43.9%
173
10.2%
9.5%
173
80.3%
4.04%
173
95.96%
Q4FY25
10.6%
Q1FY25
10.9%
166
52.5%
36.9%
142
50.5%
38.6%
10.6%
14.5%
166
15.0%
14.5%
142
74.9%
2.02%
166
97.98%
70.5%
5.8%
142
94.2%
Rs Cr
Reaction Systems
Storage, Separation & Drying Systems
Plant, Engineering Services
Pharmaceuticals
Chemicals
Others*
Domestic
Exports
11 ‹#›
QUARTER PERFORMANCE- Q1FY26
BUSINESS OVERVIEW
ANNEXURE
1212
Standard Glass Lining: A Top Ranked Specialised Engineering Equipment Company
1
2
3
4
Leading manufacturers of glass-lined, stainless steel, and nickel alloy based specialized engineering equipment
Well invested manufacturing facility with strong capabilities across chain
Deep and well-established customer relationship
Strong Distribution and Sales Network
37%
42%
19%
11%
8
11,000+
$108bn
Rs. 209 Cr
Total Revenue CAGR from FY22-25
EBITDA CAGR from FY22-25
EBITDA margins in FY25
PAT margins in FY25
Manufacturing facilities
Products delivered to customers
Large export opportunity; Global TAM
Healthy Cash in the books; Net Debt free Status
13
‹#›
13
Diversified and De-Risked Business Model
FY22
5.7%
FY23
7.8%
FY24
FY25
13.2%
13.2%
By Line of Business
26.1%
240
68.2%
31.0%
498
61.3%
30.1%
544
56.7%
614
52.3%
34.5%
By End Users Industries
13.5%
1.0%
240
14.3%
2.9%
12.5%
5.7%
498
85.5%
82.8%
By Geography
0.2%
240
99.8%
0.3%
498
99.7%
544
81.8%
0.4%
544
99.6%
12.2%
12.3%
614
75.5%
3.7%
614
96.3%
Rs Cr
Reaction Systems
Storage, Separation & Drying Systems
Plant, Engineering Services
Pharmaceuticals
Chemicals
Others*
Domestic
Exports
14 ‹#›
Strong Growth Trajectory
Total Income (In Cr)
EBITDA & EBITDA Margins
PAT & PAT Margins
CAGR:37%
CAGR:42%
CAGR:40%
500
550
626
242
88
17.6%
42
17.3%
120
19.1%
101
18.4%
69
11.0%
60
10.9%
53
10.7%
25
10.4%
FY22
FY23
FY24
FY25
FY22
FY23
FY24
FY25
FY22
FY23
FY24
FY25
EBITDA
Margins
PAT
Margins
15 ‹#›
Well Positioned in a High Growth Market
Reaction Systems (heat transfer systems, pipes & fittings, pumps, reactors)
Separation and Drying Systems (Filtration & Drying, Storage, Vessels)
Plant Engineering and Services (Services, utility systems, others)
7 6 . 1 2
1 7. 4 5
1 4 . 0 0
Global Market CY23 (USD bn)
Global Market CY23 (USD bn)
Global Market CY23 (USD bn)
TAM
1 1 4 . 5 1
3 3 . 1 2
3 0 . 0 0
India Market FY24 (INR bn)
India Market FY24 (INR bn)
India Market FY24 (INR bn)
~INR 120–150bn Capital spending in the pharmaceutical industry likely to remain at current levels or increase to INR 120-150 bn per year upto FY27 owing to local export demand & semi- regulated markets
~INR 70 Bn Capex per year of player’s in the Chemical Industry will increase by ~ 7% -to 9% CAGR until FY25-26
China +1 To facilitate robust demand potential from overseas market
16 ‹#›
SGLT-Driving India’s Next CDMO Frontier
CDMO-Fastest-growing segment, reflecting its central role in the evolving global pharma ecosystem
Global Innovator CDMO Market (In US$ Bn)
CAGR: 10%
Rising demand for outsourced drug development driven by cost efficiency, scalability, and faster time-to-market
Indian Innovator CDMO Market without China (In US$ Bn)
CAGR: 12%
Development Manufacturing
111
101
92
84
77
70
177
162
147
134
122
Expanding specialty chemical capacity + rising pharma outsourcing = powerful tailwinds for CDMO growth
Move toward integrated, flexible manufacturing solutions catering to complex drug pipelines and biologics
1.4
1.1
1.2
1.0
1.5
1.3
3.7
3.4
3.3
3.1
3.0
2.8
2.7
2.4
2.4
2.2
2.2
1.9
1.9
1.7
1.7
1.5
2024
2025E
2026E
2027E
2028E
2029E
2030E
2031E
2032E
2033E
2034E
Pharma CDMO presents a high-conviction, long-term opportunity fueled by global innovation and supply chain reconfiguration
2024
2025E
2026E
2027E
2028E
2029E
2030E
2031E
2032E
2033E
2034E
SGLT Building the Future of Pharma with Integrated CDMO Capabilities
Backed by a marquee customer base across global pharmaceutical and specialty chemical industries
Strategically expanding into niche, high-growth technology segments, with contributions expected to double in the next five years
Positioned to evolve as a comprehensive CDMO solutions provider
Source- Research Report
17 ‹#›
Business Model built on Multiple USPs
CUSTOMISED AND INNOVATIVE PRODUCT OFFERING
WELL INVESTED MANUFACTURING FACILITIES
DEEP RELATION- -SHIP WITH MARQUEE CLIENTS
INVESTING IN PROJECTS TO DRIVE FUTURE GROWTH
STRATEGIC PARTNERSHIP, AIDING IN STRENGTHENING THE BUSINESS MODEL
PROFITABLE AND SCALABLE BUSINESS MODEL
18 ‹#›
1. Customised and Innovative Product Offering
Vacuum / Pressure
RM Storage
Reaction
Filtration
Drying
Heat Exchanger
Collection of filtrate
Collection of distillate or separate layers
Heating / Cooling System for reaction
Water/Steam based system
Single fluid system
Other multifluid systems
Air Handling / Environment Management
Testing Equipment (Quality Control)
e r o C
e r o c - n o N
Capabilities
1
3
5
1 of the few companies in India offering end- to-end customized solutions
Capability to cater to customized process needs of end-users to deliver large and complex projects with a wide equipment range
2
4
Turnkey automated equipment solutions optimising processes like vacuum distillation, solvent recovery, gas dispersion
Delivered some of the largest & most complex equipment in India across Product Portfolio
Capability to manufacture process equipment using various types of alloys with thickness ranging from 1mm to 60 mm used in food, pharma & fine chemical industries
Unique Offerings
STANGLASS
No Stain Glass
Shell & Tube heat exchanger
Smart seal
Clampless Manhole
Extended Nozzles
Contributing to its leadership position
TOP 3 Process equipment manufacturers in the Pharma Industry*^
“Key Supplier” Of GMP-compliant accessories for stainless steel GLE^
TOP 3 Suppliers of multistage claw vacuum pumps in India *^
TOP 3 Stainless steel & Nickel - alloy based specialized engineering equipment for India’s Pharma & Chemical sectors*
TOP 3 with 23.3% market share Suppliers of PTFE lined pipelines and fittings in India through acquisition of the business of M/S Yashave Glass Lining Industries, M/S Higenic Flora Polymers*^
Acquisition Of business of CPK Engineers Private Limited; entity engaged in similar business to complement existing capabilities
Created strong brand equity through decades of industry expertise, technology prowess, innovative product offerings, high-reliability solutions, and the ability to deliver value to customers
*In terms of revenue in Fiscal 24. ^Source- F&S Report
GL – Glass Lined Source- F&S Report
19 ‹#›
2. Well Invested Manufacturing Facilities
8 # of Mfg. Facilities
65 Sub products across product categories
>500,000 Built-up area (sq. ft.)
30 ANFD capacity p.m.
100 Reactors p.m.
9,000 units PTFE lined pipes & fittings capacity p.m.
8 Manufacturing Facilities- SGL Unit, S2 Unit 1, S2 Unit 5, S2 Unit 3, S2 Unit 4, SFPL Unit, CPK Unit 1, CPK Unit2
30L to 40,000L Capability to mfg. products of varied sizes
300-350 units Monthly Capacity across product portfolio
20 ‹#›
3. Deep Relationship with Marquee Clients add more customers
Revenue Contribution from Top 10 & Top 20 Customers
Top 10 customer
Top 20 customer
72%
54%
58%
41%
59%
45%
62%
48%
FY23
FY24
FY25
Q1FY26
Enjoying long-standing relationships in excess of 3 years with 13 of our top 20 customers
relationships
Long-term ongoing engagements with customers allow to plan Capex and enhance ability to benefit from increasing economies of scale
and
21 ‹#›
21
4. Investing in Projects to Drive Future Growth
Planned Capex: ₹130 Crs over the next 2-3 Years; Total expansion of 5.5 lakh sq. ft.
We have invested significant capex in the past to expand our manufacturing capacities
Capex (INR Cr)
% of Capex to revenue
35%
30
12
37
30
8
5.0%
6.0%
6.9%
4.7%
4.6%
FY22
FY23
FY24
FY25
Q1FY26
FY22
FY23
FY24
FY25
Q1FY26
Intend to expand our manufacturing capacities for existing products to cater to the growing demand from our existing customers and to meet requirements of new customers
upto ₹400mn
Net Proceeds towards expansion of our existing manufacturing units and upcoming facilities
Propose to purchase new machineries and equipment to build-up additional capacity for our glass lining and stainless steel and nickel alloy equipment operations namely:
Welding Machines
Cranes
Laser Scanning cutting Machines
Addition of new facility
Installation of new Machinery
Increase production capacity
Scale operations
Onboard new customers
Introduce new products
Better serve existing customers
Reduced delivery time → Increase orders in hand
22 ‹#›
5. Strategic Partnership
Grow inorganically through strategic acquisitions and alliances
Agreement with HHV Pumps for supply of vacuum pumps with a private label arrangement.
Growth aided by other inorganic acquisitions
M/s S2 Engineering Services (metals business)
M/s Stanpumps Engineering Industries (pumps business)
C.P.K Engineers Private Limited (compliment existing capabilities)
Recently acquired the business of firms engaged in the business of manufacturing, supply,installation and repair of PTFE lined pipes and fittings
M/s Higenic Flora Polymers
2
M/s Yashasve Glass Lining Industries
A sale and purchase agreement for supply of certain grades of glass used by our glass lining division
Asahi Glassplant Inc.
2
GL Hakko
Plan to target entities that expand our opportunities in:-
1
1
Other end-markets
Geographic regions
New customers
New products
Strategic Partnership with Japan’s AGI Group to Launch World’s First Glass-Lined Shell and Tube Heat Exchangers in India
23 ‹#›
6. Profitable and Scalable Business Model
ROE/Adjusted ROE*
ROCE/Adjusted ROCE*
Total debt/Equity and Net debt/Equity
ROE
Adjusted ROE
56.2%
54.9%
50.0%
47.6%
ROCE
Adjusted ROCE
1.01
0.98
42.5%
42.0%
44.1%
43.4%
28.5%
20.7%
18.2%
11.6%
29.4%
25.5%
23.8%
19.0%
0.53
0.47
0.32
0.10
0.0
0.0
FY22
FY23
FY24
FY25
FY22
FY23
FY24
FY25
FY22
FY23
FY24
FY25
Total Debt to Equity
Net Debt to Equity
* Adjusted RoE and ROCE are calculated on average Net worth and Capital Employed net of cash.
24 ‹#›
Improving Working Capital and Strong Asset TO
W o r k i n g C a p i t a l D a y s
F i xe d A s s e t T u r n o v e r R a t i o ( x )
Receivable Days
Inventory Days
Payables Days WC Days
174
173
131
103
83
55
123
110
123
113
59
62
79
72
64
57
70
64
56
50
10.9
8.4
7.4
6.0
5.7
FY22
FY23
FY24
FY25
Q1FY26
FY22
FY23
FY24
FY25
Q1FY26
25 ‹#›
Strategic Priorities
Continue to expand and improve our existing product portfolio and enter into additional end-user industries
Capitalise on increasing demand from international markets to grow our exports
Continue to strengthen our existing product portfolio in line with our capabilities
Increasing the share of revenues from international markets
Diversify into products with prospects for increased growth and profitability
Consolidate certain of our existing facilities to achieve cost efficiencies
Continue to pursue new products within existing segments + explore the use of engineering capabilities to diversify product offerings, especially in products from related segments
Grow inorganically through strategic acquisitions and alliances
Explore & consider opportunities that can create synergies between the proposed target companies and us, and align with our growth strategy
Propose to enter into additional end-user industries
Oil & Gas
Heavy Engineering
Edible Oil
Flavours & Fragrance
Paints & Coatings
Plan to target entities that expand our opportunities in:-
Expand our team to expand our sales and marketing reach will allow us to target newer customers in Southern & Western regions of India
Other end-markets
Geographic regions
New customers
New products
26 ‹#›
QUARTER PERFORMANCE- Q1FY26
BUSINESS OVERVIEW
ANNEXURE
2727
From Vision to Reality: Our Company's Journey
Incorporated the Glass Lining Division
Sold 100 glass lined reactors.
Supplied first unique stainless-steel glass lined reactor to NATCO Pharma Limited
Hit a turnover of ₹ 500,000,000.00
Finished construction of new facility of glass lining equipment at SGL Unit
Our Material Subsidiary acquired metal business from M/s S2 Engineering Services and pumps business from M/s Stanpumps Engineering Industries
Our Material Subsidiary was incorporated as a wholly-owned subsidiary
2013
2014
2025
2016
2024
2018
2019
2021
2023
• Successful IPO; • Launch of Glass Lined Shell and Tube
Heat Exchangers,
• Operation Commenced at Unit 5, Supply
and Purchase agreement with Gale Process Solutions LLP, USA
• Incorporation of wholly owned subsidiary-
Standard Engineering Inc.
• Long-term agreement with M/s. Biocon Solutions Pte Ltd, Singapore to expand market access across Southeast Asia.
Acquired the business of Hyderabad based C.P.K. Engineers Private Limited
Resale arrangements for North America (excluding Cuba), South America, Europe (excluding Belarus and Russia) and certain countries in Asia and Africa
• Investment from AGI Investors
(Japan) in our Company
• Acquired the business of M/s Higenic Flora Polymers & M/s Yashasve Glass Lining
2022
Agreement with Climaveneta Climate Technologies Private Limited to enter the chillers market
28 ‹#›
Global Industry Growth Driving Expansion
The Global Market Opportunity –Sizing (Values in USD Bn) and CAGR (2023 – 2028E), unless specified otherwise
Glass Lined Equipment Market
Reactors (Pressure Vessels) & Storage Tanks Market
Filter & Dryers Market Overview
CAGR 10.1%
3.4
2.1
Pressure Vessels
CAGR 4.0%
70.1
58.0
Storage Tanks
CAGR 7.6%
23.1
CAGR 8.7%
2.12
16.0
1.40
2023
2028F
2023
2028F
2023
2028F
2023
2028F
Vacuum Pumps Market Overview
High-Alloy Steel & PTFE lines pipes & Fittings Market
Heat Exchangers Market Overview
CAGR 4.9%
6.6
5.2
High Alloy Steel
CAGR 5.6%
12.5
9.5
PTFE (USD mn)
CAGR 5.0%
255
200
CAGR 5.8%
16.8
12.7
2023
2028F
2023
2028F
2023
2028F
2023
2028F
Source- F&S Report
29 ‹#›
India's Expanding Industry Creating Massive Growth Opportunities for the Company
The India Market Opportunity –Sizing (Values in INR Billion) and CAGR (FY24 –FY29E), unless specified otherwise
Glass Lined Equipment Market
CAGR 10.1%
18.6
11.5
FY24
FY29F
Vacuum Pumps Market Overview
CAGR 10.1%
23.8
14.7
Reactors (Pressure Vessels and Storage tanks) Market Overview
CAGR 6.7%
95.1
68.7
Filter & Dryers Market Overview
* CAGR is from FY23-FY28F
CAGR 11.9%*
15.8
9.0
FY24
FY29F
FY24E
FY29F
High-Alloy Steel & PTFE lines pipes & Fittings Market
Heat Exchangers Market Overview
High Alloy Steel
CAGR 7.4%*
680
PTFE (INR mn)
CAGR 10.3%
1,820.4
CAGR 9.0%
83.0
1,230.0
54.0
280
FY24E
FY29F
FY24
FY28F
FY24
FY28F
FY24E
FY29F
30 ‹#›
Source- F&S Report
A Glimpse of our Plant
31 ‹#›
Well Diversified Product Portfolio
Reaction Systems (heat transfer systems, pipes & fittings, pumps, reactors)
Separation and Drying Systems FRP Moulded Gratings (Filtration & Drying, Storage, Vessels)
Plant Engineering and Services (Services, utility systems, others)
FRP Rods
AE Reactor
BE Reactor
CE Reactor
Receivers
Heat Exchanger
Pumps
Storage Tank
Conical Dryer
32 ‹#›
Introducing our Leadership Team
Kandula Nageswara Rao Promoter and Managing director
Kandula Krishna Veni Promoter and Executive Director
Kandula Ramakrishna Promoter and Executive Director
Venkata Mohana Rao Katragadda Promoter and Executive Director
Yasuyuki Ikeda Non-Executive Director (Nominee of AGI Investors)
Kallam Hima Priya Company Secretary & Compliance officer
Anjaneyulu Pathuri CF0
Kudaravalli Punna Rao Executive Vice President, Manufactur ing
Palayil Nanda Kumar Chief Marketing Officer – South India
Bhanu Prakash Kandula Vice P resident, Manufactur ing
Vara Prasad Vice P resident - Oper ations
Somanchi Datta Phani Prabhakar Gener al Ma na ger - Projects
Radhakrishna Bandi Asst. Gener al Ma na ger- Purcha se
Sambasiva Rao Gollapudi Non-Executive Chairman, Indep endent Director & Audit Committee Chairman
Sudhakara Reddy Siddareddy Indep endent Director
Radhilka Nannapaneni Independent Director
33 ‹#›
Historical Profit and Loss Statement
Particulars (All amounts are in INR Crs. except otherwise stated)
Revenue from Operations
Other Income
Total Income
COGS
Gross Profit
Total Expenditure
EBITDA
EBITDA Margins (%)
Depreciation
Profit Before Interest & Tax
Interest
Profit Before Tax (PBT)
Tax
Net Profit
Net Profit Margins (%)
Diluted Earnings Per share (Rs.)
2022
240.2
1.3
241.5
115.1
126.4
199.7
41.8
17.3%
4.2
37.5
3.8
33.8
8.6
25.1
10.4%
2.2
2023
497.6
2.5
500.1
285.5
214.6
411.8
88.3
17.6%
7.7
80.5
8.7
71.9
18.4
53.4
10.7%
3.5
2024
543.7
6.0
549.7
317.7
232.0
448.8
100.9
18.4%
9.3
91.6
11.8
79.8
19.8
60.0
10.9%
3.5
2025
613.7
12.3
626.0
344.3
281.7
506.2
119.7
19.1%
11..1
108.7
15.1
93.5
24.9
68.6
11.0%
3.5
34 ‹#›
Historical Balance Sheet
Particulars
Equity
Equity share capital
Other equity
Non-controlling interests
Total Equity
Non-current liabilities
Financial liabilities
(a) Borrowings
(b) Lease liabilities
Provisions
Deferred tax liabilities (net)
Total Non-Current Liabilities
Current liabilities
Short term borrowings
Trade payables
Short terms Provisions
Other current liabilities
Total Current Liabilities
Total Equity and Liabilities
2022
2023
2024
2025
Particulars
2022
2023
2024
2025
15.3
53.7
-
69.0
6.8
18.2
1.4
0.4
26.8
42.4
62.5
0.6
96.9
202.3
298.1
15.8
139.9
-
155.7
3.0
18.5
2.1
0.6
24.2
57.0
75.0
0.8
35.1
167.9
347.8
18.2
389.2
1.6
409.0
0.6
12.4
0.9
0.6
14.5
113.2
88.7
0.9
39.1
241.9
665.4
199.5
507.3
5.9
712.7
2.0
22.6
1.1
1.3
26.9
37.1
108.2
1.5
71.9
218.7
958.4
Non-Current Assets
Property plant and equipment
Capital work-in-progress
Right-of-use assets
Goodwill
Other intangible assets
Financial assets
(a) Loans
(b) Other financial assets
Income tax asset (net)
Other non-current assets
Total Non-Current Assets
Current Assets
Inventories
Financial assets
31.9
0.7
19.7
-
0.4
0.2
3.6
-
4.1
54.7
3.3
19.7
-
0.6
-
2.1
0.7
3.5
82.2
4.5
13.0
-
1.0
-
1.4
-
4.6
60.6
84.7
106.6
101.0
8.5
26.2
7.7
1.0
-
2.0
-
13.9
160.3
125.9
143.4
224.8
279.3
(a) Trade receivables
(b) Cash and cash equivalents
(c) Bank balances other than cash and cash equivalents
(d) Other financial assets
Other current assets
Total Current Assets
Total Assets
82.2
0.1
-
1.2
28.1
237.6
298.1
91.3
5.4
-
5.2
17.8
263.1
347.8
154.8
15.4
36.5
95.5
31.7
558.8
665.4
214.0
1.7
119.9
145.9
37.3
798.1
958.4
35 ‹#›
*All amounts are in INR Crs except otherwise stated
Thank You
Investor Relations Contact: Go India Advisors LLP
Monali Jain Go India Advisors monali@GoIndiaAdvisors.com M:+91 8078675682
Sheetal Khanduja Go India Advisors sheetal@GoIndiaAdvisors.com M:+91 97693 64166
Company Contact:
Anjaneyulu Pathuri Chief Financial Officer (CFO) anjaneyulu@standardglr.com Standard Glass Lining Technology Limited
Hima Priya Company Secretary cshima@standardglr.com Standard Glass Lining Technology Limited
Company’s Investor Relations investorrelations@standardglr.com Standard Glass Lining Technology Limited
3636